Is Dolby Laboratories Stock a Good Investment?

Dolby Laboratories Investment Advice

  DLB
To provide specific investment advice or recommendations on Dolby Laboratories stock, we recommend investors consider the following general factors when evaluating Dolby Laboratories. This will help you to make an informed decision on whether to include Dolby Laboratories in one of your diversified portfolios:
  • Examine Dolby Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Dolby Laboratories' leadership team and their track record. Good management can help Dolby Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Electronic Equipment, Instruments & Components space and any emerging trends that could impact Dolby Laboratories' business and its evolving consumer preferences.
  • Compare Dolby Laboratories' performance and market position to its competitors. Analyze how Dolby Laboratories is positioned in terms of product offerings, innovation, and market share.
  • Check if Dolby Laboratories pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Dolby Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Dolby Laboratories stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Dolby Laboratories is a good investment.
 
Sell
 
Buy
Strong Buy
Macroaxis provides advice on Dolby Laboratories to complement and cross-verify current analyst consensus on Dolby Laboratories. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Dolby Laboratories is not overpriced, please confirm all Dolby Laboratories fundamentals, including its shares owned by institutions, gross profit, debt to equity, as well as the relationship between the price to book and cash and equivalents . Given that Dolby Laboratories has a price to earning of 23.36 X, we urge you to verify Dolby Laboratories market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

InsignificantDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Dolby Laboratories Stock

Researching Dolby Laboratories' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 93.0% of the company shares are held by institutions such as insurance companies. The book value of Dolby Laboratories was currently reported as 26.03. The company has Price/Earnings To Growth (PEG) ratio of 2.08. Dolby Laboratories last dividend was issued on the 11th of February 2025.
To determine if Dolby Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Dolby Laboratories' research are outlined below:
Over 93.0% of the company shares are held by institutions such as insurance companies
On 19th of February 2025 Dolby Laboratories paid $ 0.33 per share dividend to its current shareholders
Latest headline from simplywall.st: Senior VP Chief Marketing Officer Of Dolby Laboratories Sold 100 percent Of Their Shares

Dolby Laboratories Quarterly Accounts Payable

11.55 Million

Dolby Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Dolby Laboratories. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dolby Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
1st of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View
Earnings surprises can significantly impact Dolby Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Dolby Laboratories' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2005-07-28
2005-06-300.150.13-0.0213 
2016-10-26
2016-09-300.20.230.0315 
2005-05-05
2005-03-310.170.14-0.0317 
2015-07-22
2015-06-300.30.340.0413 
2006-08-02
2006-06-300.130.170.0430 
2019-11-14
2019-09-300.480.43-0.0510 
2013-01-29
2012-12-310.450.50.0511 
2010-07-29
2010-06-300.50.550.0510 

Dolby Laboratories Target Price Consensus

Dolby target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Dolby Laboratories' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   3  Strong Buy
Most Dolby analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Dolby stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Dolby Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Dolby Laboratories Target Price Projection

Dolby Laboratories' current and average target prices are 81.69 and 100.00, respectively. The current price of Dolby Laboratories is the price at which Dolby Laboratories is currently trading. On the other hand, Dolby Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Dolby Laboratories Market Quote on 25th of February 2025

Low Price80.71Odds
High Price82.16Odds

81.69

Target Price

Analyst Consensus On Dolby Laboratories Target Price

Low Estimate91.0Odds
High Estimate111.0Odds

100.0

Historical Lowest Forecast  91.0 Target Price  100.0 Highest Forecast  111.0
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Dolby Laboratories and the information provided on this page.

Dolby Laboratories Analyst Ratings

Dolby Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Dolby Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Dolby Laboratories' financials, market performance, and future outlook by experienced professionals. Dolby Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.

Know Dolby Laboratories' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Dolby Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dolby Laboratories backward and forwards among themselves. Dolby Laboratories' institutional investor refers to the entity that pools money to purchase Dolby Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dimensional Fund Advisors, Inc.2024-12-31
901.7 K
First Trust Advisors L.p.2024-12-31
794.8 K
Charles Schwab Investment Management Inc2024-12-31
742.6 K
Norges Bank2024-12-31
708.8 K
Aqr Capital Management Llc2024-12-31
699.3 K
Northern Trust Corp2024-12-31
582 K
Fiera Capital Corporation2024-12-31
537.4 K
Jpmorgan Chase & Co2024-09-30
527.2 K
Ninety One Uk Limited2024-12-31
509.9 K
Vanguard Group Inc2024-12-31
M
Morgan Stanley - Brokerage Accounts2024-12-31
M
Note, although Dolby Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Dolby Laboratories' market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 7.85 B.

Market Cap

4.55 Billion

Dolby Laboratories' profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.14 
Return On Capital Employed 0.09  0.08 
Return On Assets 0.07  0.12 
Return On Equity 0.08  0.15 
The company has Net Profit Margin of 0.2 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.24 %, which entails that for every 100 dollars of revenue, it generated $0.24 of operating income.
Determining Dolby Laboratories' profitability involves analyzing its financial statements and using various financial metrics to determine if Dolby Laboratories is a good buy. For example, gross profit margin measures Dolby Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Dolby Laboratories' profitability and make more informed investment decisions.

Dolby Laboratories' Earnings Breakdown by Geography

Please note, the presentation of Dolby Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dolby Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Dolby Laboratories' management manipulating its earnings.

Evaluate Dolby Laboratories' management efficiency

Dolby Laboratories has Return on Asset of 0.0569 % which means that on every $100 spent on assets, it made $0.0569 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1085 %, implying that it generated $0.1085 on every 100 dollars invested. Dolby Laboratories' management efficiency ratios could be used to measure how well Dolby Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Dolby Laboratories' Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.12, whereas Return On Capital Employed is forecasted to decline to 0.08. At present, Dolby Laboratories' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 145.6 M, whereas Total Assets are forecasted to decline to about 2 B.
Last ReportedProjected for Next Year
Book Value Per Share 22.51  12.06 
Tangible Book Value Per Share 17.74  9.34 
Enterprise Value Over EBITDA 18.02  26.75 
Price Book Value Ratio 2.90  2.76 
Enterprise Value Multiple 18.02  26.75 
Price Fair Value 2.90  2.76 
Enterprise Value5.4 BB
The decision-making processes within Dolby Laboratories are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Dividend Yield
0.0162
Forward Dividend Yield
0.0162
Forward Dividend Rate
1.32
Beta
0.981

Basic technical analysis of Dolby Stock

As of the 25th of February, Dolby Laboratories shows the Mean Deviation of 1.2, downside deviation of 1.21, and Coefficient Of Variation of 1062.17. Dolby Laboratories technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Dolby Laboratories' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dolby Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dolby Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dolby Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
John Couling over two weeks ago
Disposition of 8000 shares by John Couling of Dolby Laboratories at 64.6 subject to Rule 16b-3
 
Mark Sherman over two months ago
Disposition of 7713 shares by Mark Sherman of Dolby Laboratories at 78.2208 subject to Rule 16b-3
 
Avadis Tevanian over two months ago
Acquisition by Avadis Tevanian of 2952 shares of Dolby Laboratories subject to Rule 16b-3
 
Ryan Nicholson over three months ago
Disposition of 10500 shares by Ryan Nicholson of Dolby Laboratories at 31.73 subject to Rule 16b-3
 
John Couling over three months ago
Disposition of 7000 shares by John Couling of Dolby Laboratories at 64.6 subject to Rule 16b-3
 
Dolby Dagmar over three months ago
Disposition of 500000 shares by Dolby Dagmar of Dolby Laboratories subject to Rule 16b-3
 
Kevin Yeaman over three months ago
Acquisition by Kevin Yeaman of 246 shares of Dolby Laboratories at 42.98 subject to Rule 16b-3
 
Kevin Yeaman over three months ago
Disposition of 9816 shares by Kevin Yeaman of Dolby Laboratories at 74.5467 subject to Rule 16b-3
 
John Couling over three months ago
Disposition of 21120 shares by John Couling of Dolby Laboratories at 62.32 subject to Rule 16b-3
 
Mark Sherman over three months ago
Acquisition by Mark Sherman of 5738 shares of Dolby Laboratories subject to Rule 16b-3
 
Todd Pendleton over six months ago
Disposition of 5118 shares by Todd Pendleton of Dolby Laboratories subject to Rule 16b-3
 
Kevin Yeaman over six months ago
Acquisition by Kevin Yeaman of tradable shares of Dolby Laboratories at 78.15 subject to Rule 16b-3

Dolby Laboratories' Outstanding Corporate Bonds

Dolby Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dolby Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dolby bonds can be classified according to their maturity, which is the date when Dolby Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Dolby Laboratories' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Dolby Laboratories' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Dolby Laboratories' intraday indicators

Dolby Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dolby Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Dolby Laboratories Corporate Filings

F4
21st of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
7th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
3rd of February 2025
Other Reports
ViewVerify
10Q
30th of January 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
Dolby Laboratories time-series forecasting models is one of many Dolby Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dolby Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Dolby Stock media impact

Far too much social signal, news, headlines, and media speculation about Dolby Laboratories that are available to investors today. That information is available publicly through Dolby media outlets and privately through word of mouth or via Dolby internal channels. However, regardless of the origin, that massive amount of Dolby data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dolby Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dolby Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dolby Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dolby Laboratories alpha.

Dolby Laboratories Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Dolby Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Dolby Laboratories Historical Investor Sentiment

Investor biases related to Dolby Laboratories' public news can be used to forecast risks associated with an investment in Dolby. The trend in average sentiment can be used to explain how an investor holding Dolby can time the market purely based on public headlines and social activities around Dolby Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dolby Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dolby Laboratories and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Dolby Laboratories news discussions. The higher the estimate score, the more favorable the investor's outlook on Dolby Laboratories.

Dolby Laboratories Corporate Directors

Avadis TevanianIndependent DirectorProfile
Simon SegarsIndependent DirectorProfile
David DolbyIndependent DirectorProfile
Roger SiboniIndependent DirectorProfile
When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.014
Dividend Share
1.26
Earnings Share
2.7
Revenue Per Share
13.756
Quarterly Revenue Growth
0.131
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Dolby Laboratories' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.